Positive opinion based on results of Phase 3 C-POST trial that show Libtayo significantly reduced the risk of disease recurrence or death by 68% compared to placebo (hazard ratio: 0.32; 95% confidence ...

The combination of Lenvima (lenvatinib) and Keytruda (pembrolizumab) with chemotherapy did not help patients with metastatic ...

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative ...

Kidman Park man, Joshua Giorgio died surrounded by family and friends on October 4 this year after a brave battle with oral ...

The FDA has granted breakthrough therapy designation to ficerafusp alfa with Keytruda for some patients with head and neck squamous cell carcinoma.

How Interdisciplinary Care Helped a Dental Patient Recover from Mouth Cancer ...

First-in-human trials to start Q1 2026, giving biotech blogs EVM14 keywords and trial protocol. SHANGHAI, Oct. 13, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a ...

Although exposure to ultraviolet rays is a primary cause of skin cancer, factors such as your age, sex, and smoking habits also may contribute to developing this health issue.

A new study published in Current Molecular Pharmacology identifies the DKK1:CALML5 ratio as a potential biomarker for ...

Could a daily vitamin B3 pill prevent skin cancer? New research finds nicotinamide cuts recurrence risk by more than half in ...

Opportunities in the NSCLC market include the adoption of targeted and immunotherapies such as PD-1/PD-L1 inhibitors, the potential in Asia Pacific driven by rising prevalence, and advancements in ...

Before her death on1, Diane Keaton had previously battled a series of health challenges, many of which she spoke about openly ...